MRI-Based Analysis of Post-HIFU Efficacy in Uterine Adenomyosis and Personalized Treatment Strategies
Gynecologic and Obstetric Investigation · 06.11.2026
DOI: 10.1159/goi/aczag021 ↗Kurz gefasst
Fachartikel in der Zeitschrift Gynecologic and Obstetric Investigation, online erschienen am 06.11.2026. Verfasst von Yan Chen und 6 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objectives
To evaluate the clinical outcomes of high-intensity focused ultrasound (HIFU) ablation in patients with different subtypes of adenomyosis as classified by preoperative magnetic resonance imaging (MRI), and to explore the implications for personalized treatment planning.
Design
A retrospective cohort study.
Participants
447 patients with adenomyosis who underwent HIFU treatment were classified according to the Kishi MRI criteria into Type I (intrinsic, n=195), Type II (extrinsic, n=92), Type III (intramural, n=50), and Type IV (full-thickness, n=110).
Methods
All 447 patients underwent HIFU ablation under standardized procedural protocols.Treatment parameters, non-perfused volume (NPV) ratio, relief of dysmenorrhea (assessed by NRS score), and improvement in menstrual blood volume (assessed by FPS score) were analyzed and compared across subtypes at 3 and 6 months post-treatment.
Results
Patients with Type IV adenomyosis had significantly larger lesion volumes and required longer treatment durations with higher energy delivery (p<0.001). The NPV ratio was highest in Type I (74.91% ± 28.34%), followed by Type III (70.34% ± 26.12%), both significantly higher than in Type II (60.01% ± 2.9%) and Type IV (65.93% ± 25.41%) (p<0.05). All subtypes demonstrated significant and sustained improvement in both dysmenorrhea and menorrhagia at follow-up (p<0.05). The comprehensive treatment success rate was highest for Type IV at both 3 (21.82%) and 6 months (27.27%).
Limitations
This study has several limitations. First, the retrospective design inherently introduces selection bias and limits causal inference. Second,long-term follow-up beyond 6 months was not available, precluding assessment of durability of symptom relief and recurrence rates.
Conclusions
High-intensity focused ultrasound (HIFU) provides effective symptom relief for all MRI-classified subtypes of adenomyosis. Treatment parameters and efficacy, however, vary by subtype. MRI classification is therefore crucial for guiding treatment and anticipating technical challenges. A personalized approach based on subtype may further optimize therapeutic outcomes.
Zitieren
APA
Chen, Y., Zhang, F., Wu, H., Wang, Y., He, Y., Zhou, H., & Jiang, J. (2026). MRI-Based Analysis of Post-HIFU Efficacy in Uterine Adenomyosis and Personalized Treatment Strategies. Gynecologic and Obstetric Investigation. https://doi.org/10.1159/goi/aczag021
Vancouver
Chen Y, Zhang F, Wu H, Wang Y, He Y, Zhou H, et al. MRI-Based Analysis of Post-HIFU Efficacy in Uterine Adenomyosis and Personalized Treatment Strategies. Gynecologic and Obstetric Investigation. 2026. doi:10.1159/goi/aczag021
BibTeX
@article{Chen2026,
author = {Chen, Yan and Zhang, Fangfang and Wu, Hong and Wang, Yanlin and He, Yang and Zhou, Honggui and Jiang, Jing},
title = {MRI-Based Analysis of Post-HIFU Efficacy in Uterine Adenomyosis and Personalized Treatment Strategies},
journal = {Gynecologic and Obstetric Investigation},
year = {2026},
doi = {10.1159/goi/aczag021}
}
EUVIMED